2. Signaling Pathways
  3. Anti-infection
  4. Antibiotic
  5. Macrolide Isoform

Macrolide

 

Macrolide Related Products (50):

Cat. No. Product Name Effect Purity
  • HY-100558
    Bafilomycin A1
    		99.43%
    Bafilomycin A1 (BafA1) is a specific and reversible inhibitor of vacuolar H+-ATPase (V-ATPase) with IC50 values of 4-400 nmol/mg.
  • HY-13756
    Tacrolimus
    		99.93%
    Tacrolimus (FK506), a macrocyclic lactone, binds to FK506 binding protein (FKBP) to form a complex.
  • HY-N6716
    Filipin complex
    Filipin complex is a potent broad spectrum 28-membered ring pentaene macrolide antifungal antibiotic.
  • HY-17506
    Azithromycin
    		≥98.0%
    Azithromycin is a macrolide antibiotic useful for the treatment of a number of bacterial infections.
  • HY-B0220
    Erythromycin
    		99.86%
    Erythromycin is a macrolide antibiotic produced by actinomycete Streptomyces erythreus with a broad spectrum of antimicrobial activity.
  • HY-N1724
    Concanamycin A
    		≥98.0%
    Concanamycin A (Folimycin; Antibiotic X 4357B) is a macrolide antibiotic, a vacuolar type H+-ATPase (V-ATPase) inhibitor.
  • HY-17508
    Clarithromycin
    		≥98.0%
    Clarithromycin has a broad spectrum of antimicrobial activity.
  • HY-13756A
    Tacrolimus monohydrate
    		98.88%
    Tacrolimus monohydrate (FK506 monohydrate), a macrocyclic lactone, binds to FK506 binding protein (FKBP) to form a complex and inhibits calcineurin phosphatase, which inhibits T-lymphocyte signal transduction and IL-2 transcription.
  • HY-A0062
    Telithromycin
    		99.34%
    Telithromycin (HMR3647) is a novel ketolide antibiotic that structurally resembles macrolides.
  • HY-B0133
    Natamycin
    		99.30%
    Natamycin (Pimaricin) is a macrolide antibiotic agent produced by several Streptomyces strains.
  • HY-B0435
    Roxithromycin
    		≥98.0%
    Roxithromycin (RU-28965) is a semi-synthetic macrolide antibiotic.
  • HY-B0778
    Milbemycin oxime
    		99.82%
    Milbemycin oxime is a macrocyclic lactone and has broad-spectrum anti-parasitic activity.
  • HY-B0519A
    Tylosin
    		99.81%
    Tylosin (Tylosin A) is a macrolide antibiotic found naturally as a fermentation product of Streptomyces fradiae.
  • HY-B1920
    Josamycin
    		≥98.0%
    Josamycin (EN-141) is a macrolide antibiotic exhibiting antimicrobial activity against a wide spectrum of pathogens, such as bacteria.
  • HY-116010
    Oleandomycin
    		≥99.0%
    Oleandomycin is a macrolide antibiotic structurally closely related to Erythromycin.
  • HY-17593
    Solithromycin
    		99.50%
    Solithromycin (CEM-101) is an orally bioavailable, effective antimicrobial agent, with IC50s for inhibition of cell viability, protein synthesis, and growth rate are 7.5 ng/mL, 40 ng/mL, and 125 ng/mL for Streptococcus pneumonia, Staphylococcus aureus, and Haemophilus influenzae, respectively.
  • HY-B0905
    Tilmicosin
    		≥98.0%
    Tilmicosin is a macrolide antibiotic, is used for the research of bovine respiratory disease and ovine respiratory disease associated with Mannheimia (Pasteurella) haemolytica.
  • HY-100593
    Spiramycin
    		99.19%
    Spiramycin (Rovamycin) is a macrolide antibiotic produced by Streptomyces ambofaciens with against bacteria and Toxoplasma gondii activities, and also has antiparasitic effect.
  • HY-128423
    Tylvalosin tartrate
    		98.77%
    Tylvalosin tartrate (Acetylisovaleryltylosin tartrate) is a macrolide antibiotic that can against Gram-positive bacteria.
  • HY-B1908
    Midecamycin
    		≥98.0%
    Midecamycin, an acetoxy-substituted macrolide antibiotic, is tested against gram-positive and gram-negative bacteria.